CY2021002I1 - Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης - Google Patents
Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασηςInfo
- Publication number
- CY2021002I1 CY2021002I1 CY2021002C CY2021002C CY2021002I1 CY 2021002 I1 CY2021002 I1 CY 2021002I1 CY 2021002 C CY2021002 C CY 2021002C CY 2021002 C CY2021002 C CY 2021002C CY 2021002 I1 CY2021002 I1 CY 2021002I1
- Authority
- CY
- Cyprus
- Prior art keywords
- lysosomic
- mannosidase
- recombinant
- alpha
- purification
- Prior art date
Links
- 102000019199 alpha-Mannosidase Human genes 0.000 title 1
- 108010012864 alpha-Mannosidase Proteins 0.000 title 1
- 230000001868 lysosomic effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01024—Alpha-mannosidase (3.2.1.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Dispersion Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201070067 | 2010-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2021002I1 true CY2021002I1 (el) | 2021-05-05 |
Family
ID=43920349
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100951T CY1123438T1 (el) | 2010-02-24 | 2020-10-09 | Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης |
| CY2021002C CY2021002I1 (el) | 2010-02-24 | 2021-09-20 | Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100951T CY1123438T1 (el) | 2010-02-24 | 2020-10-09 | Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US8974780B2 (el) |
| EP (2) | EP3281636B1 (el) |
| JP (1) | JP6021647B2 (el) |
| KR (1) | KR101856260B1 (el) |
| CN (1) | CN102834111B (el) |
| AU (1) | AU2011220163B2 (el) |
| BR (1) | BR112012020934B1 (el) |
| CA (1) | CA2790786C (el) |
| CY (2) | CY1123438T1 (el) |
| DK (2) | DK2538968T3 (el) |
| EA (1) | EA022220B1 (el) |
| ES (1) | ES2652330T3 (el) |
| FR (1) | FR18C1038I2 (el) |
| HK (1) | HK1179869A1 (el) |
| HR (1) | HRP20171736T1 (el) |
| HU (2) | HUE037943T2 (el) |
| LT (2) | LT2538968T (el) |
| NL (1) | NL300948I2 (el) |
| NO (2) | NO2538968T3 (el) |
| NZ (1) | NZ601790A (el) |
| PL (2) | PL3281636T3 (el) |
| PT (1) | PT2538968T (el) |
| RS (1) | RS60983B1 (el) |
| SI (2) | SI3281636T1 (el) |
| WO (1) | WO2011103877A1 (el) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9169331B2 (en) * | 2012-12-21 | 2015-10-27 | Dionex Corporation | Separation of glycans by mixed-mode liquid chromatography |
| US9310344B2 (en) | 2013-06-14 | 2016-04-12 | Dionex Corporation | HILIC/anion-exchange/cation-exchange multimodal media |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| CN108025072A (zh) * | 2015-09-22 | 2018-05-11 | 辉瑞公司 | 制备治疗用蛋白质制剂的方法和由这种方法生产的抗体制剂 |
| CN111100196B (zh) * | 2019-11-08 | 2021-07-13 | 上海交通大学 | 一种生物活性多肽qilsvpgwtysr及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL63327A (en) * | 1981-07-16 | 1985-11-29 | Yeda Res & Dev | Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria |
| US5705364A (en) * | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| JP4320870B2 (ja) | 1999-10-18 | 2009-08-26 | 住友化学株式会社 | （＋）−トランス第一菊酸の製造方法 |
| GB0007651D0 (en) * | 2000-03-29 | 2000-05-17 | Ascorbex Ltd | Gene sequence |
| US7138262B1 (en) * | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| AU2002317701A1 (en) * | 2001-06-07 | 2002-12-16 | Hemebiotech A/S | Production of recombinant human lysosomal alpha-mannosidase |
| JP4742191B2 (ja) * | 2001-06-14 | 2011-08-10 | 独立行政法人産業技術総合研究所 | 糖蛋白質およびその製造方法 |
| US7507573B2 (en) * | 2003-11-14 | 2009-03-24 | Vib, Vzw | Modification of protein glycosylation in methylotrophic yeast |
| AU2005209360B2 (en) * | 2004-01-30 | 2009-06-25 | Takeda Pharmaceutical Company Limited | Production and purification of recombinant arylsulfatase A |
| CA2556245A1 (en) | 2004-02-06 | 2005-08-25 | Biomarin Pharmaceutical Inc. | Manufacture of highly phosphorylated lysosomal enzymes and uses thereof |
| DK1740204T3 (en) * | 2004-04-01 | 2018-05-22 | Chiesi Farm Spa | MEDICAL USE OF ALFA MANNOSIDASE |
| EP2628746B1 (en) | 2006-04-04 | 2019-01-09 | Chiesi Farmaceutici S.p.A. | A process for the concentration of a polypeptide |
| CN101410408A (zh) | 2006-04-04 | 2009-04-15 | 希尔制药爱尔兰有限责任公司 | 用于浓缩多肽的方法 |
| JP5323072B2 (ja) * | 2007-07-11 | 2013-10-23 | ノボ・ノルデイスク・エー／エス | 混合方式又は多様式樹脂を使用する第ｖｉｉｉ因子の精製 |
-
2011
- 2011-02-23 JP JP2012554217A patent/JP6021647B2/ja active Active
- 2011-02-23 WO PCT/DK2011/050054 patent/WO2011103877A1/en active Application Filing
- 2011-02-23 BR BR112012020934-5A patent/BR112012020934B1/pt active IP Right Grant
- 2011-02-23 PT PT117058065T patent/PT2538968T/pt unknown
- 2011-02-23 KR KR1020127022458A patent/KR101856260B1/ko active IP Right Grant
- 2011-02-23 DK DK11705806.5T patent/DK2538968T3/en active
- 2011-02-23 NZ NZ601790A patent/NZ601790A/en unknown
- 2011-02-23 RS RS20201294A patent/RS60983B1/sr unknown
- 2011-02-23 SI SI201131925T patent/SI3281636T1/sl unknown
- 2011-02-23 CN CN201180010683.3A patent/CN102834111B/zh active Active
- 2011-02-23 EP EP17192938.3A patent/EP3281636B1/en active Active
- 2011-02-23 SI SI201131374T patent/SI2538968T1/en unknown
- 2011-02-23 HU HUE11705806A patent/HUE037943T2/hu unknown
- 2011-02-23 PL PL17192938T patent/PL3281636T3/pl unknown
- 2011-02-23 EP EP11705806.5A patent/EP2538968B1/en active Active
- 2011-02-23 DK DK17192938.3T patent/DK3281636T3/da active
- 2011-02-23 US US13/576,258 patent/US8974780B2/en active Active
- 2011-02-23 AU AU2011220163A patent/AU2011220163B2/en active Active
- 2011-02-23 ES ES11705806.5T patent/ES2652330T3/es active Active
- 2011-02-23 CA CA2790786A patent/CA2790786C/en active Active
- 2011-02-23 NO NO11705806A patent/NO2538968T3/no unknown
- 2011-02-23 PL PL11705806T patent/PL2538968T3/pl unknown
- 2011-02-23 EA EA201270715A patent/EA022220B1/ru not_active IP Right Cessation
- 2011-02-23 LT LTEP11705806.5T patent/LT2538968T/lt unknown
-
2013
- 2013-06-19 HK HK13107165.9A patent/HK1179869A1/xx unknown
-
2015
- 2015-03-02 US US14/635,681 patent/US20150306186A1/en not_active Abandoned
-
2017
- 2017-06-09 US US15/619,125 patent/US10159718B2/en active Active
- 2017-11-13 HR HRP20171736TT patent/HRP20171736T1/hr unknown
-
2018
- 2018-08-28 NL NL300948C patent/NL300948I2/nl unknown
- 2018-08-28 LT LTPA2018512 patent/LTC2538968I2/lt unknown
- 2018-08-30 HU HUS1800037C patent/HUS1800037I1/hu unknown
- 2018-09-14 FR FR18C1038C patent/FR18C1038I2/fr active Active
- 2018-09-14 NO NO2018032C patent/NO2018032I1/no unknown
-
2020
- 2020-10-09 CY CY20201100951T patent/CY1123438T1/el unknown
-
2021
- 2021-09-20 CY CY2021002C patent/CY2021002I1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255283A1 (zh) | 用於治療流感的化合物和方法 | |
| HRP20180780T1 (hr) | Liječenje gihta i hiperurikemije | |
| SMT201600254B (it) | Procedimento per la preparazione di idromagnesite | |
| CY2021002I1 (el) | Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης | |
| PL3299380T3 (pl) | Sposoby oczyszczania polipeptydów | |
| EP2628013A4 (en) | BIOMARKER FOR BRAIN INJURY | |
| IT1393456B1 (it) | Apparecchiatura e metodo per la fabbricazione di lastre ad effetto venato | |
| ZA201208172B (en) | Methods for the treatment of il-1b related conditions | |
| IT1406769B1 (it) | Procedimento per il recupero e la de-vulcanizzazione di gomma | |
| PL2627656T3 (pl) | Sposób wytwarzania dihydropterydynonów i ich produktów pośrednich | |
| BR112012021749A2 (pt) | processos e compostos | |
| ITTO20110857A1 (it) | Procedimento per la produzione di cicloesanonossina. | |
| IT1403597B1 (it) | Procedimento per il trattamento di materiali tessili | |
| FI20105730A0 (fi) | Menetelmä c-puristimen rungon valmistamiseksi, c-puristimen runko ja c-puristin | |
| ITMI20110916A1 (it) | Procedimento e dispositivo per la produzione di pannelli per mobili | |
| LT2531124T (lt) | Prietaisai odos pažeidimams gydyti | |
| IT1397894B1 (it) | Dispositivo micromeccanico e procedimento per la produzione dello stesso | |
| EP2939672A4 (en) | PROMOTER OF IGF-1 PRODUCTION | |
| BR112012029363A2 (pt) | 'método para produção de 1-alquil-3-difluormetil-5-hidroxipirazóis' | |
| IT1404615B1 (it) | Procedimento ed attrezzatura per la realizzazione di gallerie | |
| IT1400278B1 (it) | Procedimento per la fabbricazione di manufatti sinterizzati | |
| FR2962457B1 (fr) | Greement de chalut et chalut | |
| IT1402358B1 (it) | Procedimento di stampaggio ad iniezione ed apparecchiatura per la realizzazione di detto procedimento | |
| IT1403250B1 (it) | Macroapparato per la produzione e il trattamento di gas | |
| IT1406151B1 (it) | Procedimento per la preparazione di fosinopril e suoi intermedi |